Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
The preclinical pharmacology of BIBN4096BS, a CGRP antagonist
Debbie L. Hay,
David Poyner
Aston Pharmacy School
College of Health and Life Sciences
Aston Research Centre for Health in Ageing
Aston University
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The preclinical pharmacology of BIBN4096BS, a CGRP antagonist'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
CGRP Antagonist
100%
BIBN4096BS
100%
Clinical Pharmacology
100%
Pharmacology
66%
High Affinity
33%
Transfected Cells
33%
Physiological Role
33%
Cardiovascular System
33%
Cardioprotection
33%
Non-peptide Antagonists
33%
Migraine Treatment
33%
Neuropeptides
33%
Plasma Extravasation
33%
Unknown Composition
33%
Activating Receptors
33%
Human Blood Vessel
33%
Ischemia
33%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Calcitonin Gene Related Peptide
100%
Calcitonin Gene Related Peptide Receptor Antagonist
100%
Preclinical Pharmacology
100%
Migraine
25%
Clinical Study
25%
Neuropeptide
25%
Ischemia
25%
Extravasation
25%